1. Home
  2. MDCX vs UG Comparison

MDCX vs UG Comparison

Compare MDCX & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • UG
  • Stock Information
  • Founded
  • MDCX 2008
  • UG 1942
  • Country
  • MDCX Canada
  • UG United States
  • Employees
  • MDCX N/A
  • UG N/A
  • Industry
  • MDCX
  • UG Package Goods/Cosmetics
  • Sector
  • MDCX
  • UG Consumer Discretionary
  • Exchange
  • MDCX Nasdaq
  • UG Nasdaq
  • Market Cap
  • MDCX 44.0M
  • UG 36.9M
  • IPO Year
  • MDCX N/A
  • UG N/A
  • Fundamental
  • Price
  • MDCX $2.52
  • UG $8.13
  • Analyst Decision
  • MDCX Strong Buy
  • UG
  • Analyst Count
  • MDCX 2
  • UG 0
  • Target Price
  • MDCX $23.50
  • UG N/A
  • AVG Volume (30 Days)
  • MDCX 423.8K
  • UG 3.7K
  • Earning Date
  • MDCX 05-12-2025
  • UG 08-08-2025
  • Dividend Yield
  • MDCX N/A
  • UG 8.57%
  • EPS Growth
  • MDCX N/A
  • UG 4.93
  • EPS
  • MDCX N/A
  • UG 0.63
  • Revenue
  • MDCX N/A
  • UG $11,408,154.00
  • Revenue This Year
  • MDCX N/A
  • UG N/A
  • Revenue Next Year
  • MDCX N/A
  • UG N/A
  • P/E Ratio
  • MDCX N/A
  • UG $13.01
  • Revenue Growth
  • MDCX N/A
  • UG N/A
  • 52 Week Low
  • MDCX $1.80
  • UG $7.73
  • 52 Week High
  • MDCX $8.94
  • UG $16.25
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • UG 46.44
  • Support Level
  • MDCX N/A
  • UG $8.12
  • Resistance Level
  • MDCX N/A
  • UG $8.50
  • Average True Range (ATR)
  • MDCX 0.00
  • UG 0.17
  • MACD
  • MDCX 0.00
  • UG -0.00
  • Stochastic Oscillator
  • MDCX 0.00
  • UG 26.09

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: